AgenciesRelated
INSIGHTS
Read Stock Insights by ET for a quick analysis
New Delhi: Sun Pharmaceutical Industries on Friday reported a two-fold jump in consolidated net profit at Rs 1,852.48 crore for the December quarter compared with Rs 913.52 crore in the same quarter last year. The numbers were aided by other income.
Analysts in an ETNOW poll had projected the profit figure at Rs 1,260 crore.
Other income for the quarter surged to Rs 314.95 crore compared with Rs 119.88 crore in the year-ago quarter.
Revenue for the quarter rose 9.2 per cent YoY to Rs 8,781.84 crore from Rs 8,038.65 crore in the same quarter last year.
The company board has declared an interim dividend of Rs 5.50 per share. The record date fixed for the purpose of ascertaining the entitlement is February 10.
Analysts in an ETNOW poll had projected the profit figure at Rs 1,260 crore.
Other income for the quarter surged to Rs 314.95 crore compared with Rs 119.88 crore in the year-ago quarter.
Revenue for the quarter rose 9.2 per cent YoY to Rs 8,781.84 crore from Rs 8,038.65 crore in the same quarter last year.
The company board has declared an interim dividend of Rs 5.50 per share. The record date fixed for the purpose of ascertaining the entitlement is February 10.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.